ST-13 cells |
Function assay |
5 μM |
11 days |
Induction of preadipocyte differentiation in mouse ST-13 cells assessed as lipid accumulation at 5 uM within 11 days by oil red-staining relative to control |
19268587 |
HepG2 cells |
Function assay |
50 μM |
24 h |
Induction of p53 protein level in human HepG2 cells at 50 uM up to 24 hrs by immunoblot analysis |
25851939 |
HEK293 cells |
Function assay |
10 μM |
24 h |
Transactivation of PPAR-gamma transfected in HEK293 cells at 10 uM after 24 hrs by luciferase reporter gene assay |
22579484 |
HepG2 cells |
Function assay |
0.5-12.5 μM |
|
Agonist activity at PPARgamma in human HepG2 cells assessed as down-regulation of glucose-6-phosphatase at 0.5 to 12.5 uM by real-time PCR method |
22342624 |
HepG2 cells |
Function assay |
0.5-12.5 μM |
|
Agonist activity at PPARgamma in human HepG2 cells assessed as down-regulation of phosphoenolpyruvate carboxykinase at 0.5 to 12.5 uM by real-time PCR method |
22342624 |
MA104 cells |
Cytotoxicity assay |
|
24 h |
Cytotoxicity against monkey MA104 cells after 24 hrs, TD50=18.5 μM |
22365411 |
MDA-MB-231 cells |
Proliferation assay |
|
24 h |
Antiproliferative activity hormone-independent human MDA-MB-231 cells after 24 hrs by luminescent cell viability assay, IC50=15.7 μM |
22409968 |
MCF7 cells |
Proliferation assay |
|
24 h |
Antiproliferative activity hormone-dependent human MCF7 cells after 24 hrs by luminescent cell viability assay, IC50=35.4 μM |
22409968 |
HepG2 cells |
Function assay |
|
20 h |
Transactivation of GAL4-fused PPARgamma LBD expressed in HepG2 cells after 20 hrs by luminescence assay, EC50=0.73 μM |
22381047 |
LNCAP cells |
Cytotoxicity assay |
|
24 h |
Cytotoxicity against human LNCAP cells after 24 hrs by MTT assay, IC50=22 μM |
22546208 |
PC3 cells |
Cytotoxicity assay |
|
24 h |
Cytotoxicity against human PC3 cells after 24 hrs by MTT assay, IC50=30 μM |
22546208 |
CHO cells |
Function assay |
|
24 h |
Agonist activity at human PPARgamma expressed in CHO cells co-transfected with pGL3-PPRE3-TK-luc assessed as transactivation after 24 hrs by firefly luciferase reporter gene assay, EC50=0.44 μM |
22342624 |
HepG2 (DPX-2) cells |
Function assay |
|
24 h |
Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis, EC50=6.9 μM |
20966043 |
3T3-L1 cells |
Function assay |
|
|
Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells, EC50=0.13 μM |
9599241 |
PC12 cells |
Proliferation assay |
|
|
Concentration required for 50% inhibition of cell proliferation in PC12 cells using sulforhodamine B assay, IC50=15 Μm |
15109648 |
A549 |
Growth inhibition assay |
|
|
Inhibition of human lung cancer cell line (A549) by 50% in sulforhodamine B assay, GI50=15 μM |
15454234 |
3T3L1 cells |
Function assay |
|
|
Increase in 2-deoxyglucose uptake in mouse 3T3L1 cells at 3 uM by liquid scintillation counter |
18477507 |
HEK293 cells |
Function assay |
|
|
Agonist activity at PPARgamma expressed in HEK293 cells assessed as induction of receptor interaction with steroid receptor coactivator-1 by EYFP based reporter gene assay |
16680159 |
CV-1 cells |
Function assay |
|
|
Activation of peroxisome proliferator activated receptor gamma measured by induction of 50% of maximum alkaline phosphatase activity, transfection assay in CV-1 cells, EC50=0.53703 μM |
9836620 |
3T3L1 cells |
Function assay |
|
|
Agonist activity at PPARgamma in mouse 3T3L1 cells, EC50=1 μM |
21493073 |
HepG2 cells |
Function assay |
|
|
Agonist activity at PPARgamma in human HepG2 cells assessed as downregulation of phosphoenolpyruvate carboxykinase mRNA by RT-PCR analysis |
22424300 |
HEK293T cells |
Function assay |
|
|
Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis, IC50=4.5 Μm |
23122865 |
HepG2 cells |
Function assay |
|
|
Agonist activity at PPARgamma in human HepG2 cells assessed as downregulation of glucose-6-phosphatase mRNA by RT-PCR analysis |
22424300 |
HEK293 cells |
Function assay |
|
|
Activation of PPARgamma transfected in HEK293 cells after 18 hrs by firefly luciferase reporter gene-based luminescence assay relative to control, EC50=0.4 μM |
21800856 |
rat ventricular myocytes |
Function assay |
|
|
Inhibition of L-type calcium channel measured using whole-cell patch clamp in rat ventricular myocytes, IC50=9.5 μM |
22761000 |
CV1 cells |
Function assay |
|
|
Transactivation of human PPARgamma expressed in african green monkey CV1 cells by luciferase reporter gene assay, EC50=0.4 μM |
22579420 |
CHO cells |
Function assay |
|
|
Agonist activity at human recombinant PPARgamma expressed in CHO cells cotransfected with pGL3-PPRE3-TK-luc reporter assessed as beta-galactosidase activity at after 24 hrs by luciferase based transactivation assay, EC50=0.44 μM |
22424300 |
HepG2 cells |
Function assay |
|
|
Transactivation of GAL4-fused PPARgamma ligand binding domain transfected in human HepG2 cells after 20 hrs by luciferase reporter gene assay, EC50=0.72 μM |
23031596 |